ZYBERNO
Stock Report
Updated Aug 24, 2026

TANKE BIOSCIENCES CORP (TNBI)

Consumer Staples • Over The Counter

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
33.0/100
WEAK BUSINESS
TANKE BIOSCIENCES CORP (TNBI) scores 33/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-10.4%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.12x)
Operating Margin (Operational Efficiency):CRITICAL (-0.2%)
Return on Capital (Capital Efficiency):EXCELLENT (27.5%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

TANKE BIOSCIENCES CORP (TNBI) stock report — Zyberno Score 33/100 (WEAK BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, TNBI generated $4.45M in Owner Earnings. Capital was deployed as follows: $3.04M invested in capital expenditures. Reinvestment rate: 6.5%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (1)

Market Cap:$250.49K

Valuation Multiples (4)

P/B Ratio:0.02x
P/S Ratio:0.01x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:-$2.93M
Ev Ebitda Ratio:-5.06x

Price Action & Momentum (1)

% of 52-Week High:32.8%
B. Profitability Assessment

Return Metrics (5)

ROA:-5.7%
Reinvestment Rate:6.5%
Fundamental Growth Rate (g):1.8%

Margin Analysis (3)

Operating Margin Ttm:-0.2%
Net Margin Ttm:-7.1%
Ebitda Margin:2.5%

TTM Performance (3)

Gross Margin Ttm:32.3%
Operating Margin Ttm:-0.2%
Net Margin Ttm:-7.1%

Yield Metrics (3)

Earnings Yield:$20.58
Owner Earnings Yield:$687.73
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):2.9%

Cash Flow Growth (Linear) (1)

Operating Cash Flow Growth Rate (Linear):41.6%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):-24.6%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.61x
Quick Ratio:1.48x
Cash Ratio:0.41x

Leverage Analysis (3)

Debt To Equity Ttm:0.12x
Debt-to-Equity Ratio:0.12x
Debt To Ebitda:3.23x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:7,461,070.00
Cash And Cash Equivalents:5,053,700.00
Long Term Debt:$732.65K
Net Debt:-$3.18M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $22.96M
Linear Growth: 2.9%
📊 Click to view full TNBI Revenue analysis & methodology →
Cost Of Revenue Ttm:$15.55M

Profitability Breakdown (2)

Gross profit TTM: $7.41M
Linear Growth: -4.4%
📊 Click to view full TNBI Gross Profit analysis & methodology →
Operating income TTM: -$57.27K
Linear Growth: -24.6%
📊 Click to view full TNBI Operating Income analysis & methodology →

Bottom Line Performance (3)

-$1.64M
Income Before Tax:-$339.85K
Ebitda Ttm:579,018.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:108,448.00
Sga Expense:1,358,109.00
Income Tax Expense:-$26.91K
Interest Expense:-46,575.00

Expense Ratios (3)

R And D To Revenue Percentage:1.8%
Sga To Revenue Percentage:22.5%
Ebitda Margin:2.5%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$28.81M
Current Assets:$19.70M
Ppe Net:6,339,399.00
Goodwill:0.00
Intangible Assets:$1.15M

Liability Structure (4)

Total Liabilities:13,097,747.00
Current Liabilities:12,235,108.00
Long Term Debt:$732.65K
Short Term Debt:$1.14M

Equity & Capital (3)

Equity:$15.56M
Retained Earnings:$1.63M
Common Stock:13,324.00

Working Capital Items (3)

Accounts Receivable:2,760,884.00
Inventory:1,649,230.00
Accounts Payable:640,777.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $4.82M
Linear Growth: 41.6%
-$2.04M

Investment Activities (2)

Investing Cash Flow:-$2.47M
Capital Expenditures Ttm:3,039,470.00

Financing Activities (3)

Financing Cash Flow:-$170.20K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$964.80K
Long Term Debt Repayments:$1.21M

Non-Cash Items (1)

Depreciation Amortization Ttm:369,911.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):0.01
$0.01
Earnings Per Share Ttm:-$0.02

Revenue & Cash Per Share (2)

Sales Per Share Ttm:2.14
Operating Cash Flow Per Share:-$0.09

Book Value & Capital (2)

Book Value Per Share:$1.17
Cash Per Share:0.38

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.99x
Working Capital Turnover Ttm:3.83x

Receivables Management (2)

Receivables Turnover Ttm:10.35x
Days Sales Outstanding Ttm:35.28

Inventory Management (2)

Inventory Turnover Ttm:11.29x
Days Inventory Outstanding Ttm:32.33

Payables & Cash Cycle (2)

Days Payable Outstanding:12.56
Cash Conversion Cycle:55.05
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:115.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $4.45M
Linear Growth: 0.0%
📊 Click to view full TNBI Owner Earnings analysis & methodology →
Owner Earnings Per Share:$0.33
Owner Earnings Yield:$687.73

Damodaran Growth Analysis (2)

Reinvestment Rate:6.5%
Fundamental Growth Rate (g):1.8%

Investment Assessment (1)

Buffett Assessment:Overvalued
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (2)

Revenue Growth Rate (Linear):2.9%
Operating Income Growth Rate (Linear):-24.6%

Cash Flow Growth Rates (1)

Operating Cash Flow Growth Rate (Linear):41.6%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-4.4%
Book Value Growth Rate (Linear):3.1%
C. Company Profile & Context

Corporate Information (6)

Symbol:TNBI
Company Name:TANKE BIOSCIENCES CORP
Sector:Consumer Staples
Industry:Grain Mill Products
Exchange:Over The Counter
Country:Unknown

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:13.32M
Shares Outstanding Basic:13.32M
Shares Outstanding Diluted:13.32M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-24 16:29:28 UTC
Data Timestamp:2026-03-28T19:05:01.539398
Scroll to Top